Syed S Javaid, Kainaat Zahid, Haider Ashfaq, Sara Rahman, Sufyan Shahid, Mohammad B Abbasi, Sarmad Imran, Pawan K Thada, Aqsa Mengal, Hira Habib, Muhammad S Ullah, Sagar Kumar, Sabeeh K Farooqui
{"title":"Seasonal variations in hospitalizations of heart failure patients: a United States nationwide analysis.","authors":"Syed S Javaid, Kainaat Zahid, Haider Ashfaq, Sara Rahman, Sufyan Shahid, Mohammad B Abbasi, Sarmad Imran, Pawan K Thada, Aqsa Mengal, Hira Habib, Muhammad S Ullah, Sagar Kumar, Sabeeh K Farooqui","doi":"10.23736/S2724-5683.25.06873-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Heart failure (HF) remains a leading cause of hospitalization globally, exerting significant strain on healthcare systems and impacting patients' quality of life. Seasonal changes in climate and temperature are known to affect HF-related outcomes. This study investigates the seasonal variations in hospitalization outcomes among HF patients in the United States.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of the National Inpatient Sample (NIS) database, focusing on patients aged over 18 years with a primary diagnosis of HF from 2018 to 2020, using the ICD-10-CM codes. Our primary outcomes of interest included trends in clinical characteristics, inpatient mortality rates, and length of hospital stay (LOS). In addition, inflation-adjusted healthcare costs for each patient were also analyzed. Statistical analyses included weighted logistic and linear regression, adjusting for patient-level factors (age, sex, race, comorbidities, insurance type, and median household income) and hospital-level factors (bed size, region, and teaching status). Inpatient mortality, length of stay, and inflation-adjusted hospital costs were analyzed. Mortality risk factors were assessed using multivariate models, with costs converted to 2019 dollars using standardized inflation adjustments.</p><p><strong>Results: </strong>We identified 3,820,865 weighted HF hospitalizations, with peak admissions in winter (32.20%), followed by spring (29.73%), autumn (28.68%), and summer (9.39%). The mean patient age was highest in winter (69.5±0.06 years) and lowest in summer (68.7±0.07 years), P<0.001. Comorbidities showed seasonal variations, with hypertension, diabetes, and obesity more prevalent in summer, while acute myocardial infarction was more frequent in winter. White, Hispanic, and Asian/Pacific Islander patients experienced higher winter hospitalizations, whereas Black patients had increased admissions in autumn. Hospitalizations were most common among patients in the lowest income quartile (33.23%). The overall in-hospital mortality rate was 2.28%, highest in winter (2.40%) and lowest in summer (2.11%), P<0.001. The average length of stay (LOS) was 5.24 days (95% CI: 5.20-5.28), increasing from 5.19 days (95% CI: 5.12-5.25) in 2018 to 5.31 days (95% CI: 5.25-5.38) in 2020. Inflation-adjusted costs rose from $57,166 in 2018 to $65,961 in 2020, with significant seasonal differences.</p><p><strong>Conclusions: </strong>Seasonal variations markedly influence HF-related hospitalizations and outcomes, with winter showing the highest hospitalization and mortality rates, especially among White, Hispanic, and Asian/Pacific Islander patients.</p>","PeriodicalId":18668,"journal":{"name":"Minerva cardiology and angiology","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva cardiology and angiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.23736/S2724-5683.25.06873-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Heart failure (HF) remains a leading cause of hospitalization globally, exerting significant strain on healthcare systems and impacting patients' quality of life. Seasonal changes in climate and temperature are known to affect HF-related outcomes. This study investigates the seasonal variations in hospitalization outcomes among HF patients in the United States.
Methods: We conducted a retrospective analysis of the National Inpatient Sample (NIS) database, focusing on patients aged over 18 years with a primary diagnosis of HF from 2018 to 2020, using the ICD-10-CM codes. Our primary outcomes of interest included trends in clinical characteristics, inpatient mortality rates, and length of hospital stay (LOS). In addition, inflation-adjusted healthcare costs for each patient were also analyzed. Statistical analyses included weighted logistic and linear regression, adjusting for patient-level factors (age, sex, race, comorbidities, insurance type, and median household income) and hospital-level factors (bed size, region, and teaching status). Inpatient mortality, length of stay, and inflation-adjusted hospital costs were analyzed. Mortality risk factors were assessed using multivariate models, with costs converted to 2019 dollars using standardized inflation adjustments.
Results: We identified 3,820,865 weighted HF hospitalizations, with peak admissions in winter (32.20%), followed by spring (29.73%), autumn (28.68%), and summer (9.39%). The mean patient age was highest in winter (69.5±0.06 years) and lowest in summer (68.7±0.07 years), P<0.001. Comorbidities showed seasonal variations, with hypertension, diabetes, and obesity more prevalent in summer, while acute myocardial infarction was more frequent in winter. White, Hispanic, and Asian/Pacific Islander patients experienced higher winter hospitalizations, whereas Black patients had increased admissions in autumn. Hospitalizations were most common among patients in the lowest income quartile (33.23%). The overall in-hospital mortality rate was 2.28%, highest in winter (2.40%) and lowest in summer (2.11%), P<0.001. The average length of stay (LOS) was 5.24 days (95% CI: 5.20-5.28), increasing from 5.19 days (95% CI: 5.12-5.25) in 2018 to 5.31 days (95% CI: 5.25-5.38) in 2020. Inflation-adjusted costs rose from $57,166 in 2018 to $65,961 in 2020, with significant seasonal differences.
Conclusions: Seasonal variations markedly influence HF-related hospitalizations and outcomes, with winter showing the highest hospitalization and mortality rates, especially among White, Hispanic, and Asian/Pacific Islander patients.